{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T21:12:03Z","timestamp":1770585123434,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.ejps.2011.10.028","type":"journal-article","created":{"date-parts":[[2011,11,10]],"date-time":"2011-11-10T06:31:37Z","timestamp":1320906697000},"page":"110-115","source":"Crossref","is-referenced-by-count":13,"title":["Synthesis, stability and pharmacological evaluation of a novel codrug consisting of lamivudine and ursolic acid"],"prefix":"10.1016","volume":"45","author":[{"given":"Yan","family":"Zhong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZhaoHui","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YanBo","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejps.2011.10.028_b0005","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejps.2011.03.012","article-title":"Synthesis, characterization and in vitro hydrolysis of a gemfibrozil-nicotinic acid codrug for improvement of lipid profile","volume":"43","author":"Amjad","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ejps.2011.10.028_b0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0378-5173(85)90010-9","article-title":"Prodrugs of 5-fluorouracil. III. Hydrolysis kinetics in aqueous solution and biological media, lipophilicity and solubility of various 1-carbamoyl derivatives of 5-fluorouracil","volume":"23","author":"Anders","year":"1985","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejps.2011.10.028_b0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.dld.2005.06.004","article-title":"Suspected drug-induced liver fatalities reported to the WHO database","volume":"38","author":"Bjornesson","year":"2006","journal-title":"Dig. Liver Dis."},{"issue":"5","key":"10.1016\/j.ejps.2011.10.028_b0020","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jhep.2008.12.018","article-title":"Early changes of hepatitis B virus quasi species during lamivudine treatment and the correlation with antiviral efficacy","volume":"50","author":"Chen","year":"2009","journal-title":"J. Hepatology"},{"issue":"7","key":"10.1016\/j.ejps.2011.10.028_b0025","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1016\/j.ejmech.2010.03.029","article-title":"Design, synthesis, and pharmacological evaluation of the aqueous prodrugs of desmethyl anethole trithione with hepatoprotective activity","volume":"45","author":"Chen","year":"2010","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejps.2011.10.028_b0030","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ejps.2010.09.014","article-title":"Codrug: an efficient approach for drug optimization","volume":"41","author":"Das","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.ejps.2011.10.028_b0035","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1016\/S0957-4166(98)00447-9","article-title":"Lipase catalyzed regio- and stereospecific hydrolysis: chemoenzymatic synthesis of both (R)- and (S)-enantiomers of \u03b1-lipoic acid","volume":"23","author":"Fadnavis","year":"1998","journal-title":"Tetrahedron: Asymmetry"},{"issue":"S1","key":"10.1016\/j.ejps.2011.10.028_b0040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1055\/s-2005-915648","article-title":"Clinical trial results of new therapies for HBV: implications for treatment guidelines","volume":"25","author":"Gish","year":"2005","journal-title":"Semin. Liver Dis."},{"issue":"1","key":"10.1016\/j.ejps.2011.10.028_b0045","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.antiviral.2007.01.002","article-title":"Anti-hepatitis B virus activity of wogonin in vitro and in vivo","volume":"74","author":"Guo","year":"2007","journal-title":"Antiviral Res."},{"issue":"1","key":"10.1016\/j.ejps.2011.10.028_b0050","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jep.2008.03.024","article-title":"In vivo and in vitro anti-hepatitis B virus activity of total phenolics from Oenanthe javanica","volume":"118","author":"Han","year":"2008","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.ejps.2011.10.028_b0055","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.bmcl.2008.11.050","article-title":"Synthesis of novel twin drug consisting 8-oxaendoethanotetrahydromorphides with a 1, 4-dioxane spacer and its pharmacological activities: \u03bc, \u03ba, and putative \u03b5 opioid receptor antagonists","volume":"19","author":"Hideaki","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.ejps.2011.10.028_b0060","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0168-8278(97)80476-X","article-title":"Lamivudine resistance in immunocompetent chronic hepatitis B. Incidence and patterns","volume":"26","author":"Honkoop","year":"1997","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.ejps.2011.10.028_b0065","first-page":"3","article-title":"The characteristics of hydrolysis of triolein catalyzed by wheat germ lipase in water-in-oil microemulsions","volume":"24\u201325","author":"Jing","year":"2003","journal-title":"J. Mol. Catal. B: Enzym."},{"issue":"1","key":"10.1016\/j.ejps.2011.10.028_b0070","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.yrtph.2009.03.003","article-title":"Drug-induced liver injury following positive drug rechallenge","volume":"54","author":"Julie","year":"2009","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejps.2011.10.028_b0075","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.1840010511","article-title":"Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis","volume":"1","author":"Knodell","year":"1981","journal-title":"Hepatology"},{"issue":"20","key":"10.1016\/j.ejps.2011.10.028_b0080","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1021\/jm00072a010","article-title":"Chemistry, binding affinities, and behavioral properties of a new class of \u201cantineophobic\u201d mitochondrial DBI receptor complex (mDRC) ligands","volume":"36","author":"Kozikowski","year":"1993","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejps.2011.10.028_b0085","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1021\/bc700193d","article-title":"Synthesis, analysis, in vitro characterization, and in vivo disposition of a lamivudine\u2013dextran conjugate for selective antiviral delivery to the liver","volume":"18","author":"Krishna","year":"2007","journal-title":"Bioconjug. Chem."},{"issue":"8","key":"10.1016\/j.ejps.2011.10.028_b0090","doi-asserted-by":"crossref","first-page":"794","DOI":"10.2174\/138161208784007653","article-title":"Scope and limitations of the co-drug approach to topical drug delivery","volume":"14","author":"Lau","year":"2008","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.ejps.2011.10.028_b0095","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0378-8741(95)90032-2","article-title":"Pharmacology of oleanolic acid and ursolic acid","volume":"49","author":"Liu","year":"1995","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.ejps.2011.10.028_b0100","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/faat.1994.1005","article-title":"The effects of 10 triterpenoid compounds on experimental liver injury in mice","volume":"22","author":"Liu","year":"1994","journal-title":"Fundam. Appl. Toxicol."},{"issue":"22","key":"10.1016\/j.ejps.2011.10.028_b0105","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1056\/NEJM200205303462202","article-title":"Chronic hepatitis B","volume":"346","author":"Lok","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ejps.2011.10.028_b0110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0928-0987(02)00159-8","article-title":"Biological and metabolic study of naproxen-propyphenazone mutual prodrug","volume":"17","author":"Mahmoud","year":"2002","journal-title":"Eur. J. Pharm. Sci."},{"issue":"26","key":"10.1016\/j.ejps.2011.10.028_b0115","doi-asserted-by":"crossref","first-page":"9083","DOI":"10.1021\/jo971076p","article-title":"Synthesis and reactivity of 5-fluorouracil\/cytarabine mutual prodrugs","volume":"62","author":"Menger","year":"1997","journal-title":"J. Org. Chem."},{"issue":"2","key":"10.1016\/j.ejps.2011.10.028_b0120","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jep.2010.07.023","article-title":"In vivo hepatoprotective activity of the aqueous extract of Artemisia absinthium L. against chemically and immunologically induced liver injuries in mice","volume":"131","author":"Nurmuhammat","year":"2010","journal-title":"J. Ethnopharmacol."},{"issue":"51","key":"10.1016\/j.ejps.2011.10.028_b0125","doi-asserted-by":"crossref","first-page":"8585","DOI":"10.1016\/j.vaccine.2007.09.072","article-title":"Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: A randomized, controlled study of co-administration of HBsAg\/AS02 candidate vaccine and lamivudine","volume":"25","author":"Pierre","year":"2007","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.ejps.2011.10.028_b0130","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.lfs.2005.05.060","article-title":"Protective effect of ursolic acid on ethanol-mediated experimental liver damage in rats","volume":"78","author":"Rajendnasozhan","year":"2006","journal-title":"Life Sci."},{"issue":"7","key":"10.1016\/j.ejps.2011.10.028_b0135","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.bmcl.2006.01.003","article-title":"Synthesis and stability of two indomethacin prodrugs","volume":"16","author":"Shyamala","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"12","key":"10.1016\/j.ejps.2011.10.028_b0140","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.ejmech.2005.07.006","article-title":"Synthesis, anti-HIV and antitubercular activities of lamivudine prodrugs","volume":"40","author":"Sriram","year":"2005","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejps.2011.10.028_b0145","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0928-0987(03)00198-2","article-title":"Kinetics of degradation of 4-imidazolidinone prodrug types obtained from reacting prilocaine with formaldehyde and acetaldehyde","volume":"20","author":"Susan","year":"2003","journal-title":"Eur. J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.ejps.2011.10.028_b0150","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ejps.2004.04.013","article-title":"Kinetics of degradation and oil solubility of ester prodrugs of a model dipeptide (Gly-Phe)","volume":"22","author":"Susan","year":"2004","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ejps.2011.10.028_b0155","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.antiviral.2009.05.002","article-title":"Anti-hepatitis B virus activity of chlorogenic acid, quinic acid and caffeic acid in vivo and in vitro","volume":"83","author":"Wang","year":"2009","journal-title":"Antiviral Res."},{"issue":"3","key":"10.1016\/j.ejps.2011.10.028_b0165","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.bmcl.2005.10.014","article-title":"Pentacyclic triterpenes. Part 2: Synthesis and biological evaluation of maslinic acid derivatiaes as glycogen phosphorylase inhibitors","volume":"16","author":"Wen","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2011.10.028_b0170","series-title":"Homo and Heterodimer Ligands: The Twin Drug Approach","first-page":"380","article-title":"The Practice of Medicinal Chemistry","author":"Wermuth","year":"2008"},{"issue":"13","key":"10.1016\/j.ejps.2011.10.028_b0175","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1016\/j.bmcl.2010.05.050","article-title":"Development of acetaminophen proline prodrug","volume":"20","author":"Wu","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2011.10.028_b0180","unstructured":"Zhong, Y., Zhou, J.P., Huo, M.R. Preparation and application of a novel lamivudine codrug. CN Patent 10\/101766632."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098711003885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098711003885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T18:21:21Z","timestamp":1543429281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098711003885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":35,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0928098711003885"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2011.10.028","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}